Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Diarrhea Discontinuations in Early-stage HER2+ Breast Cancer Patients Treated with Neratinib, Loperamide, and Colesevelam
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study to Improve Tolerance of Sacituzumab Govitecan with Loperamide and Filgrastim in Patients with Advanced Triple-Negative or Luminal Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
Not recruiting
Investigated Drugs:
+4
Study of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1